Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium. (Q40449697)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 May 2007

edit

Language	Label	Description	Also known as
English	Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.	scientific article published on 17 May 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

title

Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

main subject

California

0 references

author

David I Quinn

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Timothy Synold

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Don J. Diamond

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Simon F Lacey

series ordinal

5

object named as

Simon F Lacey

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Janice P Dutcher

series ordinal

8

object named as

Janice P Dutcher

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

author name string

Kim Margolin

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Primo Lara

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Paul Frankel

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Tracey Baratta

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

Bixin Xi

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

David R Gandara

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

publication date

17 May 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

published in

Journal of Cancer Research and Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

volume

133

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

page(s)

705-711

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

cites work

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00432-007-0200-6

retrieved

21 January 2018

Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in metastatic renal cell carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of bcl-2 in small cell lung carcinoma cells.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the bcl-2 gene product in follicular lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 in the treatment of renal cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense strategies for oncogene inactivation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Bcl-2 protein family: arbiters of cell survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17508219

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00432-007-0200-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

PubMed publication ID

17508219

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17508219

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508219%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 December 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40449697&oldid=2203697950"